CSPC Pharmaceutical Group Limited (CSPCY)
OTCMKTS · Delayed Price · Currency is USD
4.810
-0.240 (-4.75%)
Aug 7, 2025, 3:17 PM EDT
Revance Therapeutics Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of $14.94 billion as of August 8, 2025. Its market cap has increased by 64.94% in one year.
Market Cap
14.94B
Enterprise Value
13.98B
Revenue
3.73B
Ranking
n/a
PE Ratio
25.86
Stock Price
$4.81
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 89.97M to 14.94B, an increase of 16,508.44%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 14.10B | 98.50% |
| Dec 31, 2024 | 7.10B | -35.50% |
| Dec 29, 2023 | 11.01B | -12.12% |
| Dec 30, 2022 | 12.53B | -3.19% |
| Dec 31, 2021 | 12.94B | 5.86% |
| Dec 31, 2020 | 12.23B | -17.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |